Results 41 to 50 of about 1,083 (145)
De Novo Psychiatric Disorders in a Woman With Giant Prolactinoma Treated With Cabergoline
Clinical Medicine Insights: Case Reports, 2023 Dopamine agonists are the first-line treatment of prolactinomas. The risk of developing de novo psychiatric symptoms during dopamine agonist therapy is low.
Chayma Belhadj Slimane +4 more
doaj +1 more source
Giant prolactinoma, a case report and review of the literature
Journal of Clinical and Translational Endocrinology Case Reports, 2019 A 13 year old boy presented with acute onset of sudden severe headache and visual impairment following a one-year history of intermittent frontal headache. Serum prolactin level was 17532ng/ml (normal 3–24ng/ml). Magnetic resonance imaging showed a large
Doua K. Al Homyani +4 more
doaj +1 more source
miR‐34a is upregulated in AIP‐mutated somatotropinomas and promotes octreotide resistance
International Journal of Cancer, Volume 147, Issue 12, Page 3523-3538, 15 December 2020., 2020 Abstract Pituitary adenomas (PAs) are intracranial tumors associated with significant morbidity due to hormonal dysregulation, mass effects and have a heavy treatment burden. Growth hormone (GH)‐secreting PAs (somatotropinomas) cause acromegaly‐gigantism.
Eva‐Maria Bogner +8 more
wiley +1 more source
A Case of Giant Prolactinoma Presented as a Nasopharyngeal Mass
Endocrinology Research and Practice, 2014 Giant prolactinomas may present with atypical tumor mass effects, as they are characterized by massive extrasellar invasion. Nasopharyngeal involvement of prolactinoma is a rare condition and it has been described in some case reports in the literature ...
Alev Selek +4 more
doaj +1 more source
F1000Research, 2018 Background: Pituitary disorders spectrum includes a wide variety of diseases.This study aimed at a comprehensive description of such disorders for patients from Faiha Specialized Diabetes, Endocrine and Metabolism Center (FDEMC) in Basrah (Southern Iraq)
Abbas Ali Mansour +11 more
doaj +1 more source
A clinical case of effective treatment of giant prolactinoma in patient with morbid obesity
Ожирение и метаболизм, 2014 Numerous studies showed an association between prolactin levels and body weight, with increased prevalence of obesity in patients with prolactinomas. Recent data indicate potential positive influence of cabergoline treatment to metabolic disorders in ...
doaj +1 more source
Radiology Case Reports, 2023 The characterization of sellar and suprasellar lesions is reliant on patient presentation, medical imaging, and hormone profiling. Prolactinomas are the most common type of functional pituitary adenomas, accounting for up to 57%.
Nikita Ollen-Bittle, MSc +4 more
doaj +1 more source
Head &Neck, Volume 48, Issue 4, Page 1088-1096, April 2026.ABSTRACT Background To evaluate postoperative health‐related quality of life (HRQoL) for pituitary adenoma patients, multidimensional assessment is important. Available data is limited on long‐term follow‐up. Methods Prospectively, 52 nonfunctioning (NFA) and functioning (FA) pituitary adenoma patients were included.
Gonneke E. Joustra +7 more
wiley +1 more source
Case Reports in Endocrinology, Volume 2026, Issue 1, 2026.Adrenal insufficiency (AI) is characterized by inadequate steroid hormone production and is frequently a consequence of hypopituitarism, which is also associated with increased risk of osteoporosis due to deficiencies in growth hormone, gonadotropins, and other pituitary hormones.
Abrar Mohammed AlFaifi +2 more
wiley +1 more source
Clinical and Genetic Spectrum of Large AIP Deletions
Human Mutation, Volume 2026, Issue 1, 2026.Familial isolated pituitary adenoma (FIPA) accounts for approximately 2%–5% of all pituitary adenomas, with inactivating variants of the aryl hydrocarbon receptor‐interacting protein (AIP) gene representing the most frequent known genetic cause.
Tea Shehu Kolnikaj +15 more
wiley +1 more source